Form 4: BlackRock Senior MD Sells Shares
Insider Transaction Report
BlackRock Senior Managing Director Stephen Cohen reported the sale of 2,179 shares of common stock at $1,073.87 per share.
Summary
- Stephen Cohen, a Senior Managing Director and Officer of BlackRock, Inc. (BLK), disposed of 2,179 shares of common stock.
- The transaction occurred on February 11, 2026, with each share sold at a price of $1,073.87.
- Following this transaction, Stephen Cohen beneficially owns 6,543 shares of common stock directly.
- The remaining beneficial ownership includes both common stock and Restricted Stock Units (RSUs) that are set to vest over a period of 1 to 3 years, with each RSU convertible into an equal number of common stock shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. A routine insider sale of this magnitude by a Senior Managing Director is generally not considered a significant indicator of the company's future performance or a material change in sentiment.
Future Outlook
This Form 4 filing reports a past insider transaction and does not contain any forward-looking statements or guidance regarding BlackRock's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales, such as the one reported by Stephen Cohen, are common occurrences for executives and senior management. These transactions often relate to personal financial planning, liquidity needs, or tax obligations, and do not necessarily reflect a change in the company's fundamental prospects or the insider's confidence in the company.
Stakeholder Impact
- Shareholders: The sale is a routine insider transaction and is unlikely to have a significant direct impact on the broader shareholder base or the company's stock price given BlackRock's size and market capitalization.
Key Dates
| Date | Description |
|---|---|
| 02/11/2026 | Date of transaction where Stephen Cohen disposed of shares. |
| 02/13/2026 | Date the Form 4 was signed by the Attorney-in-Fact for Stephen Cohen. |
Recommendation
holdA routine insider sale, while a factual disclosure, does not typically alter the fundamental investment thesis for a large, established financial institution like BlackRock. Investors should continue to evaluate the company based on its financial performance, strategic initiatives, and broader market conditions rather than a single insider transaction.
Keywords
BlackRock, BLK, Form 4, Insider Transaction, Stock Sale, Stephen Cohen, Senior Managing Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.